What should you know about activated B-cell lymphoma?

It is often abbreviated ABC-DLBCL. The term describes the lymphoma's cell-of-origin pattern; it does not mean that normal B cells have simply become active. Diagnosis requires examination of lymphoma tissue, and the subtype is considered alongside stage, symptoms, blood results, and general health.

Diffuse large B-cell lymphoma is a fast-growing non-Hodgkin lymphoma. Cell-of-origin testing separates tumours with an activated B-cell-like pattern from other molecular patterns. The result can refine the diagnosis and may influence whether additional tumour tests or particular treatment options are considered.

A pathology report may use a laboratory classification that approximates cell of origin rather than a full gene-expression result. Ask the haematologist which method was used and whether another test would change management. The subtype name by itself cannot describe where lymphoma is present or predict one person's course.

Treatment planning commonly brings together the biopsy, imaging such as PET-CT, blood tests, heart or organ assessment when relevant, current medicines, and day-to-day fitness. Initial therapy often includes a combination of systemic medicines. Radiotherapy may be useful in selected situations, while cellular therapy or stem-cell transplant may be discussed if lymphoma returns or does not respond.

Before therapy starts, report fever or infection symptoms and ask which vaccinations or medicines need adjustment. Keep the team's daytime and after-hours numbers available. During treatment, record temperature and new symptoms as instructed, and do not take fever-reducing or herbal products without checking because they may mask problems or interact with treatment.

Contact the oncology service immediately for fever, shaking chills, new shortness of breath, confusion, uncontrolled bleeding, or feeling suddenly very unwell during treatment. Follow the temperature threshold and emergency route given by your own team, because infection with low white blood cells can worsen quickly.

Emergency assessment is also needed for swelling of the face or neck with breathing difficulty, new weakness or numbness, loss of bladder or bowel control, a seizure, or severe chest pressure. Drenching night sweats can occur in lymphoma; report new or worsening sweats promptly, particularly with fever, weight loss, or enlarging swellings.

Ask whether the final diagnosis is ABC-DLBCL, how cell of origin was determined, and whether the tissue showed other features that affect treatment. Clarify the treatment goal, how response will be assessed, which side effects require an immediate call, and what options would remain if the first treatment does not control the lymphoma.